A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Supplemental material, Supplementary_materials for Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer by Fengfeng Wang, Fei Meng, Sze Chuen Cesar Wong, William C.S. Cho, Sijun Yang and Lawrence W.C. Chan in Therapeutic Advances in Respiratory Diseasedoi:10.25384/sage.12514445.v1 fatcat:plvxyf27aba4zedqpmly7go32m